oseltamavir phosphate
- Product NDC
- 68071-3741
- Requested package NDC
- 68071-3741-1
- 11-digit product format
- 680713741
- Labeler code
- 68071
- Product ID
- 68071-3741_28dd9191-b186-b651-e063-6394a90a3831
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oseltamavir phosphate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA207211
- Marketing category
- ANDA
- Marketing start
- 2017-09-21
- Substance
- OSELTAMIVIR PHOSPHATE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207211-001 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | |
| A207211-002 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | |
| A207211-003 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207211-001 | AB |
| A207211-002 | AB |
| A207211-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207211-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2017-09-14 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207211-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A207211-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A207211-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A207211-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207211-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207211-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207211-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207211-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207211-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207211-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207211-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207211-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207211-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207211-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207211-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207211-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207211-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207211-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- oseltamavir phosphate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OSELTAMIVIR PHOSPHATE | 45 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4A3O49NGEZ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 728113 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 28ddaeb7-5903-4b59-e063-6294a90a2bcd | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6022fcc-885e-41f7-971c-fe19ade5d9ba | Product name | 9 | 20190926 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3741-1 | oseltamavir phosphate | 1 in 1 CARTON | CAPSULE | 1 | 1 | |
| 68071-3741-1 | oseltamavir phosphate | 10 in 1 BLISTER PACK | CAPSULE | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3741 | OSELTAMAVIR PHOSPHATE CAPSULE [NUCARE PHARMACEUTICALS, INC.] | 1 | Current NDC, 2 package rows | 20241211_28ddaeb7-5903-4b59-e063-6294a90a2bcd.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Macleods Pharmaceuticals Limited | e9307620-36bd-46c2-a8b2-027d3fba87ba | 2025-06-18 | Warnings, Adverse reactions | 207211 ANDA207211 |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | NuCare Pharmaceuticals,Inc. | 80511c6f-88b9-62d3-e053-2991aa0ab936 | 2025-02-06 | Warnings, Adverse reactions | 207211 ANDA207211 |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | NuCare Pharmaceuticals, Inc. | 28ddaeb7-5903-4b59-e063-6294a90a2bcd | 2024-12-09 | Warnings, Adverse reactions | 207211 ANDA207211 68071-3741-1 68071-3741 68071374101 |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | Proficient Rx LP | 09e119eb-a8fa-4635-96a7-1b134593cdca | 2022-11-01 | Warnings, Adverse reactions | 207211 ANDA207211 |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | Proficient Rx LP | ccdb124d-fd56-409a-8615-ae0f675cd8e4 | 2020-02-01 | Warnings, Adverse reactions | 207211 ANDA207211 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 728113 | oseltamivir phosphate 45 MG Oral Capsule | PSN | 28ddaeb7-5903-4b59-e063-6294a90a2bcd | 1 |
| 728113 | oseltamivir 45 MG Oral Capsule | SCD | 28ddaeb7-5903-4b59-e063-6294a90a2bcd | 1 |
| 728113 | oseltamivir (as oseltamivir phosphate) 45 MG Oral Capsule | SY | 28ddaeb7-5903-4b59-e063-6294a90a2bcd | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-3741-1 | 68071374101 | 1 BLISTER PACK in 1 CARTON (68071-3741-1) / 10 CAPSULE in 1 BLISTER PACK | 1 blister pack | 2024-12-09 | No | No | Current |